Showing results (181-190 of 262) with videos related to
Sort By:
Pageof 27
Anti-Cancer Drugs|September 22, 2011
Antimetastatic activity isolated from Colocasia esculenta (taro)Namita Kundu, Patricia Campbell, Brian Hampton, et al.International Journal of Nanomedicine|January 22, 2008
Early diagnosis of oral cancer based on the surface plasmon resonance of gold nanoparticlesJames Chen Yong Kah, Kiang Wei Kho, Caroline Guat Leng Lee, et al.Artificial Organs|March 30, 2004
Lentivirus-based gene delivery in mouse embryonic stem cellsYoshikazu Kosaka, Naoya Kobayashi, Takuya Fukazawa, et al.Frontiers in Oncology|February 21, 2022
Metabolic Risks Are Increasing in Non-B Non-C Early-Stage Hepatocellular Carcinoma: A 10-Year Follow-Up StudyYen-Po Lin, Pei-Ming Wang, Ching-Hui Chuang, et al.Journal of Inflammation Research|December 15, 2021
Chinese Herbal Medicine Suyin Detoxification Granule Inhibits Pyroptosis and Epithelial-Mesenchymal Transition by Downregulating MAVS/NLRP3 to Alleviate Renal InjuryYiye Zhu, Guoshun Huang, Yang Yang, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 24, 2006
A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1Mohammad Saleem, Vaqar Mustafa Adhami, Weixiong Zhong, et al.Journal of Dermatological Science|March 22, 2016
Increased matriptase zymogen activation by UV irradiation protects keratinocyte from cell deathChi-Yung Chen, Cheng-Jueng Chen, Chih-Hsin Lai, et al.Journal of Food Biochemistry|January 5, 2022
Artemisia capillaris Thunb. water extract attenuates adriamycin-induced renal injury by regulating apoptosis through the ROS/MAPK axisGuoshun Huang, Yiye Zhu, Chen Yong, et al.American Journal of Physiology. Cell Physiology|October 28, 2011
Mechanisms for the control of matriptase activity in the absence of sufficient HAI-1Han Xu, Zhenghong Xu, I-Chu Tseng, et al.Oncotarget|March 17, 2018
Hepatocyte growth factor activator inhibitor type-2 (HAI-2)/<i>SPINT2</i> contributes to invasive growth of oral squamous cell carcinoma cellsKoji Yamamoto, Makiko Kawaguchi, Takeshi Shimomura, et al.Pageof 27